Application of Stem Cells in Bone and Cartilage RegenerationView this Special Issue
Review Article | Open Access
Binwu Hu, Ruijun He, Kaige Ma, Zhe Wang, Min Cui, Hongzhi Hu, Saroj Rai, Baichuan Wang, Zengwu Shao, "Intervertebral Disc-Derived Stem/Progenitor Cells as a Promising Cell Source for Intervertebral Disc Regeneration", Stem Cells International, vol. 2018, Article ID 7412304, 11 pages, 2018. https://doi.org/10.1155/2018/7412304
Intervertebral Disc-Derived Stem/Progenitor Cells as a Promising Cell Source for Intervertebral Disc Regeneration
Intervertebral disc (IVD) degeneration is considered to be the primary reason for low back pain. Despite remarkable improvements in both pharmacological and surgical management of IVD degeneration (IVDD), therapeutic effects are still unsatisfactory. It is because of the fact that these therapies are mainly focused on alleviating the symptoms rather than treating the underlying cause or restoring the structure and biomechanical function of the IVD. Accumulating evidence has revealed that the endogenous stem/progenitor cells exist in the IVD, and these cells might be a promising cell source in the regeneration of degenerated IVD. However, the biological characteristics and potential application of IVD-derived stem/progenitor cells (IVDSCs) have yet to be investigated in detail. In this review, the authors aim to perform a review to systematically discuss (1) the isolation, surface markers, classification, and biological characteristics of IVDSCs; (2) the aging- and degeneration-related changes of IVDSCs and the influences of IVD microenvironment on IVDSCs; and (3) the potential for IVDSCs to promote regeneration of degenerated IVD. The authors believe that this review exclusively address the current understanding of IVDSCs and provide a novel approach for the IVD regeneration.
Low back pain (LBP) is one of the most common musculoskeletal disorders causing a tremendous socioeconomic burden to the patients due to lost productivity and increasing health care costs [1–3]. Although numerous and complex causes are involved in the pathogenesis of LBP, the intervertebral disc (IVD) degeneration appears to be the foremost cause [4, 5]. However, established treatments of IVD degeneration (IVDD), including medical and surgical treatments, are mainly focused on alleviating the symptoms rather than treating the underlying cause or restoring the structure and biomechanical function of the IVD [6–8].
The loss of disc cell viability and functionality plays a critical role in disturbing disc homeostasis, which reduces biosynthesis of extracellular matrix (ECM) components and triggers the IVDD [9, 10]. Therefore, cell-based therapy and regenerative medicine aiming at restraining or even reverting the loss of disc cell number and function have attracted much attention in the field of IVD regeneration . Currently, a number of therapeutic modalities, such as growth factor supply, gene therapy and the delivery of functional cells, have been developed in order to rescue the disc cells [12–15]. Of these, the delivery of functional cells is, possibly, a promising therapeutic strategy. Many different kinds of functional cells from different areas of the body, i.e., nucleus pulposus cells (NPCs), bone marrow mesenchymal stem cells (BMSCs), adipose stem cells (ASCs), muscle-derived stem cells, synovial stem cells, induced pluripotent stem cells, olfactory neural stem cells, hematopoietic stem cells, and embryonic stem cells, can be successfully transplanted into the IVD with a hope to repair or regenerate the IVD . Owing to wide availability and multilineage differentiation potential, the stem cells (SCs) have been extensively used and have shown a promising result in animal models and clinical trials [17, 18]. However, some obstacles are always hindering the further application of SCs in disc regeneration. These problems include puncture injury during SC extraction from the tissues and formation of osteophytes in the degenerated disc due to the leakage of SCs [19, 20]. Moreover, the microenvironment of IVD is characterized by excessive mechanical loading, high osmolarity, limited nutrition, acidic pH, and low oxygen tension [21–23]. Such microenvironment might impair the viability, proliferation, and ECM biosynthesis abilities of transplanted SCs leading to a limited repair potential [21–23]. Thus, it is desperately necessary to identify novel cell sources for IVD regeneration.
Many tissues have been identified to contain adult tissue-specific SCs, also known as endogenous SCs [24–26]. These endogenous SCs are capable of balancing the homeostasis of the tissues by regulating their own proliferation and differentiation. Therefore, endogenous stem/progenitor cells are regarded as a promising cell source for regenerating tissues because of the potential of overcoming the obstacles related to cell transplantation . The IVD is the largest avascular structure in the body, which has been previously thought to have a little or poor self-repair capacity in adult mammals . Nevertheless, many previous studies have indicated that the resident SCs exist both in normal and degenerated IVD and are referred to as IVD-derived stem/progenitor cells (IVDSCs) [28–31]. These cells can be isolated from different compartments of IVD, including nucleus pulposus (NP), annulus fibrosus (AF), and cartilage endplate (CEP) and can express most of the phenotype markers that define MSCs [29, 32–36]. Furthermore, it is also proven that there exists SC niche (SCN) within the IVD, which is confined around the perichondrium region adjacent to the epiphyseal plate (EP) and outer zone of the AF [6, 27]. Thus, promoting self-repair via mobilizing the endogenous SCs might be a prospective approach for stem cell-based therapy and the IVD regeneration. However, as a novel cell subset in IVD, our knowledge about IVDSCs remains largely limited.
Therefore, authors aim to perform a review to systematically discuss (1) the isolation, surface markers, classification, and biological characteristics of IVDSCs; (2) the aging- and degeneration-related changes of IVDSCs and the influences of IVD microenvironment on IVDSCs; and (3) the potential for IVDSCs to promote regeneration of degenerated IVDSCs. The authors believe that this review exclusively addresses the current understanding of IVDSCs and provides a novel approach for the IVD regeneration.
2. Identification of IVDSCs
In 2007, Risbud et al. identified a cluster of cells in human degenerated IVD that express the surface markers of SCs and could perform adipogenic, osteogenic, and chondrogenic differentiation . Similarly, other studies also detected the cells presenting similar characteristics in all components of human IVD including the AF, NP, CEP, and putative SCN [6, 30, 32, 36]. These cells could be classified into MSCs according to the criteria established by the International Society for Cellular Therapy (ISCT) (for example, the plastic-adherent growth; the expression of CD105, CD73, and CD90 and the lack of expression of CD45, CD34, CD14 or CD11b, CD79alpha or CD19, and HLA-DR surface molecules; and multilineage differentiation ability in vitro) [30, 32, 37, 38]. From these reports, we can conclude that the endogenous SCs, also called IVDSCs, definitely exist within IVD. It has been isolated, not only from the human being but also from many other species including murine, rhesus macaque, porcine, and rabbit [6, 31, 39–42].
3. Classification of IVDSCs
The normal IVD is composed of three distinct components: the central gelatinous NP, the outer AF, and the upper and lower CEP . Based on the different anatomical regions of IVD, the IVDSCs are usually divided into three subsets, which are referred to as NP-derived stem cells (NPSCs), AF-derived stem cells (AFSCs), and CEP-derived stem cells (CESCs), respectively [28, 30, 36, 38]. Recently, some researchers propose the existence of SCN, a dynamic microenvironment consisting of the ECM and neighboring cells with the ability to regulate local SCs, within IVD [20, 27, 44]. Through a series of in vivo labeling procedures, the SCN is recognized as the perichondrium region adjacent to the EP and outer zone of the AF (Figure 1) [6, 20, 27]. Moreover, cells extracted from the SCN also meet the criteria defining MSCs . Therefore, SCN-derived stem cells (SCNSCs) might be another classification of the IVDSCs .
However, classifying the IVDSCs into absolutely different four groups might not be completely reasonable when taking the sources of IVDSCs into account. Many researches have demonstrated that the SCs in SCN could migrate into the AF, NP, and CEP along certain routes [27, 44]. Our previous experiments also confirmed that the SCs in SCN could migrate into the inner part of IVD during the process of compression-induced IVD degeneration. Furthermore, results from Xiong et al. illustrated that the CESCs could migrate from CEP to NP tissue, and the migration could be inhibited by macrophage migration inhibitory factor . In addition, the SCs might be infiltrated from growing vessels during disc degeneration, and adjacent bone marrow might also be the source in IVD [14, 46]. Despite the location of SCs in the different region, the SCNSCs, AFSCs, NPSCs, and CESCs possibly contain a proportion of cells having the same origin and biological characteristics. Hence, the SCs distributed in different anatomical regions of IVD are both independent and relevant. In Figure 1, we displayed the hypothetical distribution of IVDSCs according to different anatomic regions.
4. Isolation of IVDSCs
To date, many techniques have been developed to isolate stem/progenitor cells from different parts of the IVD. Generally speaking, most extraction methods are designed based on the distinct characteristics of SCs such as rapid proliferation rate, colony formation capacity, and unique surface markers [31, 38, 47, 48].
The SCs are characterized by their self-renew and rapid-proliferation capacity, which make them superior to other cells located in IVD in plastic-adherent and proliferation speed. Based on the above theory, differential adhesion method was developed to successfully isolate cells meeting the criteria of MSCs [47, 49, 50]. The main step of this method is to discard culture medium together with suspension cells and fragments when cell suspensions are seeded about 24 h later, and the remaining adherent cells are regarded as SCs without any further isolation . Using this method, researchers have successfully isolated NPSCs from human and other species [11, 39, 47, 50, 51].
Colony formation is another important property of SCs. The cells with stem/progenitor cell characteristics survive at 50 cells/cm2, while other types of cells die due to loss of cell-cell contacts or undergo dissolution because of the low proliferation velocity . Thus, colony formation assay might be another way to separate IVDSCs. Using this method, also named as limiting dilution method, Liu et al. extracted AFSCs from rabbit AF tissue, and they found an initial seeding density of 200 cells/cm2 to be optimal for the formation of colonies . Similarly, rat NPSCs were also successfully isolated using this method . For this method, the cell seeding density is the most critical because inappropriate cell density would cause the difficulty of colony formation or the failure of the SC extraction.
Some special culture medium is also utilized to isolate the IVDSCs. Agarose suspension culture is a chondrocyte selective culture system, in which chondrocytes are the only cell type to survive apart from tumor cells . Employing the agarose culture system, the NPSC, AFSC, and CESC were all successfully isolated [32, 36, 38, 45, 53]. Methylcellulose semisolid medium, a culture system established to identify tissue-specific stem/progenitor cells from various organs, is also applied to extract the IVDSCs, and the NPSCs had been extracted through this method [31, 54]. In addition, some researchers including our group successfully extracted IVDSCs by using standard MSC expansion medium [55, 56].
Except for the above methods, the explant culture technique and fluorescence-activated cell sorter (FACS) cell sorting have also been developed to isolate IVDSCs [23, 31]. And some researchers even isolated IVDSCs directly by cell culture without any special treatment [30, 43, 57]. Besides that, some important points must be taken into consideration during the isolation of IVDSCs. Firstly, the blood cells must be thoroughly removed to avoid the contamination of SCs. Then, when isolating IVDSCs from human samples, the age and degeneration grade of patients must be taken into account, which might influence the quantity and quality of the IVDSCs . So, the technique such as FACS cell sorting should be carried out to purify the IVDSCs meticulously.
5. Surface Marker of IVDSCs
The currently identified surface markers for IVDSCs are shown in Table 1. However, Sakai et al. demonstrated that some surface markers exist both in NP cells and NPSCs . Thus, we must realize that the cells expressing these markers are not necessarily the IVDSCs. Therefore, it is quite exigent to explore the distinct surface markers of IVDSCs. From another aspect, the expression of surface markers is associated with functional status of the IVDSCs. For example, CD105 is related to cell migration, and the expression of Tie2 and GD2 indicates the differentiation of NPSCs [31, 32]. Additionally, the IVDSCs can express neural stem cell-associated surface markers. Some researchers have proven that AFSCs could perform neurogenesis differentiation and NPSCs could differentiate into Schwann-like cells [35, 54].
6. Biological Characteristics of IVDSCs
The biological characteristics of IVDSCs (given that the concept of SCNSCs is not received so far, we only discuss the NPSCs, AFSCs, and CESCs in this chapter) have been comprehensively explored. It has been displayed that all three kinds of IVDSCs share almost the same morphology and immunophenotype [30, 32, 34, 35, 38]. For proliferation capacity, Liang et al. demonstrated that NPSCs and AFSCs had stronger cell proliferation capacity than that of CESCs . At the same time, results from Wang et al. exhibited that there was no significant difference in proliferation ability among NPSCs, AFSCs, and CESCs . Additionally, for multilineage differentiation ability, Liang et al. concluded that the expression of different lineage differentiation-related genes of AFSCs was stronger than that of NPSCs and CESCs . Wang et al. comprehensively compared the pluripotency of IVDSCs. They found that the osteogenic and chondrogenic capacities to be superior in CESCs followed by AFSCs and NPSCs; similarly, the adipogenic capacity to be superior in NPSCs followed by CESCs and AFSCs. However, when cultured in alginate bead, the CESCs consistently showed superior chondrogenic potential when comparing with rest of the cell types . It seems that IVDSCs isolated from different anatomical regions have different biological characteristics. This phenomenon might be ascribed to the special microenvironment of different IVD components . Furthermore, for the discrepancy in biological properties of IVDSCs among the studies, we speculate that this might be associated with different isolation technique, passaging, and culture protocols .
The IVDSCs also contain some special features that are different from other SCs. The CESCs are reported to have better osteogenic and chondrogenic ability as compared to BMSCs, while the NPSCs that were isolated from degenerated NP tissue showed much lower adipogenic differentiation ability [29, 32]. Wu et al. demonstrated that compared to umbilical cord mesenchymal stem cells (UCMSCs), NPSCs isolated from degenerated IVD displayed impaired proliferation capability and differentiation potential . Furthermore, when cultured in a disc mimicking microenvironment, the NPSCs are more resistant to hypoxic and acidic pH microenvironment as compared to ASCs, making NPSCs preferable cell sources for IVD regeneration [11, 51].
7. The Aging- and Degeneration-Related Changes of IVDSCs
It is a proven fact that the disc cells undergo a series of biologic changes as they become old and degenerated. These changes include alternation of cell type in NP, decrease in number of viable cells, and increase in cell senescence . Similarly, aging and degeneration also alter the quantity and quality of IVDSCs. With the progression of aging and degeneration, the number of cells expressing stem/progenitor cell markers in IVD tissues decreases markedly, indicating the exhaustion of IVDSCs [31, 41]. In Zhao et al.’s report, the aged NPSCs demonstrated deteriorative capacities of proliferation, colony forming, and multilineage differentiation but had more senescent features . For degeneration-related changes, previous studies have shown that the NPSCs derived from degenerated NP have impaired ability in colony formation, chemotactic migration, proliferation, and have less expression of stem cell markers and stemness genes [42, 43]. In addition, these NPSCs exhibit notably inferior chondrogenic differentiation ability . Owing to these aging- and degeneration-related changes, the failure of endogenous repair of IVD is inevitable. Thus, preventing or even reverting the changes incurred by aging or degeneration will be of great necessity in recovering or promoting the endogenous repair of IVD.
The DNA damage, telomere shortening, oxidative stress, and disturbance of the intracellular homeostasis contribute to the initiation of IVDD by causing cell senescence and programmed cell death [62–65]. With aging and degeneration, the degradation of misfolded proteins and clearance of toxic cellular waste products are constrained, making it difficult to maintain the homeostasis and resulting in a presenescence state [66, 67]. When the presenescence SCs are in quiescence, their intrinsic homeostasis can still be maintained . However, once the presenescence SCs is activated to exert the endogenous repair function, it is difficult to maintain normal physiological activities and then die . Therefore, repair capability of these subhealthy SCs can be restored by restoration of the cellular homeostasis, where autophagy may play a significant role. Sousa-Victor et al. reversed senescence and restored the regenerative properties of old muscle satellite cells in an injury model by promoting autophagy . Sousa-Victor et al. reported that rapamycin, an agonist of autophagy, had antisenescence effects on AFSCs but inhibited the differentiation of AFSCs under multilineage induction, thus maintaining the stemness . However, appropriate differentiation of SCs is also vital to IVD regeneration. So, precise regulation of the autophagy is required in order to keep the SCs in the right direction towards tissue repair.
8. The Influences of IVD Microenvironment on IVDSCs
The SCs are enclosed in a tissue-specific microenvironment that significantly influences their biological and metabolic vitality. The special microenvironment of the IVD is characterized by low oxygen tension, excessive stress or strain, hypertonicity, low pH, and poor nutrient supply, which present challenges to the survival and the function of implanted or endogenous SCs .
One overriding characteristic of disc cells is that they are resided under conditions of hypoxia due to the lack of blood supply. Under hypoxia, the NPSCs exhibit better cell proliferation ability than ASCs, and its chondrogenic capacity is enhanced when compared to normoxic environment . For CESCs, hypoxic precondition might weaken the differentiation in osteogenic induction, indicating the antimineralization effect of hypoxia . Thus, physiological hypoxia may be beneficial to exert normal physiological functions of IVDSCs. However, during the process of degeneration, blood vessels might invade into IVD through the fissures, which might increase the oxygen levels and disrupt the physiological hypoxic microenvironment of the IVDSCs [71, 72]. Therefore, restoring the hypoxic microenvironment may favor IVDSC-based endogenous repair of IVD.
In addition to hypoxia, excessive mechanical loading is another crucial microenvironmental factor. The disc-specific biomechanical features have been shown to exert a wide range of impacts on the biological functions of IVDSCs. In vitro studies have demonstrated that cyclic tensile stress would induce apoptosis of CESCs via the BNIP3/Bcl-2 pathway, whereas static compression stress would induce mitochondrial apoptosis in NPSCs [56, 59]. Besides the induction of cell death, stress stimuli are also essential for the normal function of SCs [73–75]. For example, it has been proven that the proportion of ECM components synthesized by AFSCs changes with fluid shear stress . These results indicate the double-edged sword effects of mechanical loading. Therefore, further studies should focus on exploring various methods to protect IVDSCs from excessive mechanical loading-induced cell death and dysfunction. In the meanwhile, the biomimetic matrix would also be produced by optimizing mechanical stimulation for in vitro cultured IVDSCs.
Moreover, hypertonicity, low pH, and poor nutrient supply are also important microenvironmental factors and are detrimental for implanted or endogenous SCs. The osmotic pressure of healthy NP, AF, and CEP (450~550 mOsm/L) is distinctly higher than the normal blood (280~320 mOsm/L) . Nevertheless, the SC-related researches taking high osmolarities into consideration are still scarce. Tao et al. pioneered the investigation regarding the influence of osmotic pressure on IVDSCs . They found that high osmolarity could decrease the viability, proliferation, and expression levels of SOX-9, aggrecan, and collagen II in NPSCs . Regarding the influences of low pH, Han et al. compared ASCs with NPSCs which were cultured in an acidic environment . They found NPSCs to be less inhibited in proliferation and cell viability . Liu et al. further illuminated that in NPSCs, the acid-sensing ion channel (ASIC) plays an important role in acid-induced apoptosis and the downregulation in stem cell-related genes and ECM synthesis . Furthermore, it was also demonstrated that the nutrition deficiency could cause mitochondrial translocation of BNIP3 in CESCs, leading to caspase-dependent apoptosis .
9. The Influences of ECM on IVDSCs
With the degeneration of IVD, the cell clustering and cell death make it more difficult to maintain the balance between anabolism and catabolism of ECM and further aggravate the tissue dysfunction [79, 80]. When investigating the IVDSCs in vitro, importance of ECM in the original tissue is often ignored. However, the cell-matrix interactions are essential in modulating not only the morphology and phenotype but also the function of SCs, and that has been successfully demonstrated in NP tissue [81, 82]. Perlecan, the common component of many SCNs, is found to be produced by progenitor cells located in this region [83–85]. In addition, it plays a positive role in chondrogenic differentiation of the mesenchymal progenitor cells in IVD [86, 87]. The changes in mechanical strength of the ECM in degenerated discs may be transmitted to the cell membrane and activate the IVDSCs via perlecan or other components of SCN [88, 89]. Moreover, the Piezo1 ion channel exists in human NP cells and underlies mechanical force-induced apoptosis via mediating the mitochondrial dysfunction and endoplasmic reticulum stress . Similar mechanosensitive ion channels that function between ECM and cells are continued to be discovered. Nevertheless, whether there are other mechanisms in the modulation of stem cells’ fate, and how the IVDSCs react with the alternation in mechanics, requires further studies.
Tissue engineering relies on suitable seed cells and scaffold materials. The biomechanical properties of scaffold materials affect the function of IVDSCs and determine the efficiency of IVD regeneration [91–94]. The natural molecules that make up the ECM of the IVD are a good choice of scaffold material. The laminin that exists in normal NP tissue, but is absent in degenerated NP tissue, attracts the attention of researchers [95–97]. Nerurkar et al. have presented a novel strategy using anisotropic nanofibrous laminates seeded with MSCs to replicate the form and function of the AF . In addition, in vitro influences of laminins on the proliferation and chondrogenesis of SCs have also been demonstrated [99, 100]. Moreover, the SCs also produce laminins which in turn enhance the regeneration ability [101, 102]. Another important component of ECM in IVD is collagen II, which promote the differentiation of SCs, especially the chondrogenic differentiation in a concentration-dependent manner . When cultured in a high concentration of collagen II, the ASCs express a high level of collagen II, aggrecan, SOX9, and low levels of collagen I, which is associated with cross-talk mechanisms between MAPK/ERK and Smad3 pathways [103, 104]. The small leucine-rich proteoglycans (SLRPs) are reported to be the key molecules in modulating the physiological and pathological process of SCs by binding to collagens, growth factors, and other matrix components in the niche of tendon  and articular cartilage , as well as IVD . The SLRPs might act as a unique niche component regulating the activities of IVDSCs through hypoxia-inducible factor (HIF), thus allowing the survival of these cells under low oxygen tension . In conclusion, the components of the ECM in IVD play a significant role in activation, self-renew, and differentiation of IVDSCs. However, the positive effects of these natural molecules on promoting IVD regeneration rely on optimistic space and time, which remains to be further elucidated [82, 108, 109].
10. The Potential of IVDSCs for IVD Regeneration
Endogenous neural stem cells react to stroke and spinal cord injury by generating a significant number of new neural cells . In the brain, neural stem/progenitor cells might play a supportive role in the cortex to promote neuronal survival and glial cell expansion after traumatic brain injury . Even more encouraging, using a surgical method preserving the endogenous lens epithelial stem/progenitor cells, Lin et al. successfully achieved the regeneration of functional lens in rabbits and macaques, as well as in human infants with cataracts . Thus, motivating the IVDSCs to promote endogenous repair of IVD seems to be a prospective method for IVD regeneration. It has been proven that SCNSCs migrate toward and into IVD tissue following the intercellular space direction of the lamellae . Huang et al. also proposed that stimulating endogenous SCs with simvastatin might retard the progression of IVDD . Chen et al. further proved that transplantation of NPSCs has superior regenerative efficacy than transplantation of NP cells for treating IVDD in rabbit models . However, current researches about the regenerative potential of IVDSCs are still scarce. Additionally, some endogenous factors might inhibit the migration of IVDSCs. For example, Xiong et al. have demonstrated that macrophage migration inhibitory factor secreted by NP cells could inhibit the migration of CESCs . Therefore, further studies are desperately needed to explore the approaches of promoting the endogenous repair of IVD.
The IVD itself has endogenous stem/progenitor cells, which satisfy the criteria defining the MSCs. Compared to other SCs, the IVDSCs might be an excellent cell source for IVD regeneration due to the following advantages: (1) the IVDSCs are generally extracted from surgical specimens derived from patients with disc herniation. Thus, IVDSCs are more accessible and could avoid the damage caused by isolating other kinds of SCs, such as BMSCs. (2) IVDSCs are superior to other SCs in tolerating the harsh microenvironment of IVD.
However, there are some limitations in understanding of IVDSCs. First, current researches about IVDSCs are scarce. Therefore, we only have limited knowledge about the biological characteristics of IVDSCs. Then, surface markers of IVDSCs are still controversial and more specific markers are needed to identify IVDSCs in vivo and in vitro. Furthermore, how to isolate purer IVDSCs simply and economically is still waiting for exploration. Finally, how to protect IVDSCs from aging, degeneration, and harsh microenvironment is not fully elucidated. In conclusion, the IVDSCs might play a pivotal role in the regeneration of IVD, but more studies are necessary.
Conflicts of Interest
The authors declare that they have no competing interests.
Binwu Hu and Ruijun He contributed equally to this work.
This study was supported by grant 2016YFC1100100 from The National Key Research and Development Program of China, grant 81501916 from the National Natural Science Foundation of China, grant 91649204 from the Major Research Plan of National Natural Science Foundation of China, and grant 30872610 from the National Natural Science Foundation of China.
- A. Maetzel and L. Li, “The economic burden of low back pain: a review of studies published between 1996 and 2001,” Best Practice & Research Clinical Rheumatology, vol. 16, no. 1, pp. 23–30, 2002.
- X. Luo, R. Pietrobon, S. X Sun, G. G. Liu, and L. Hey, “Estimates and patterns of direct health care expenditures among individuals with back pain in the United States,” Spine, vol. 29, no. 1, pp. 79–86, 2004.
- W. F. Stewart, J. A. Ricci, E. Chee, D. Morganstein, and R. Lipton, “Lost productive time and cost due to common pain conditions in the US workforce,” JAMA, vol. 290, no. 18, pp. 2443–2454, 2003.
- M. C. Battié, T. Videman, E. Levalahti, K. Gill, and J. Kaprio, “Heritability of low back pain and the role of disc degeneration,” Pain, vol. 131, no. 3, pp. 272–280, 2007.
- S. Chen, X. Lv, B. Hu et al., “RIPK1/RIPK3/MLKL-mediated necroptosis contributes to compression-induced rat nucleus pulposus cells death,” Apoptosis, vol. 22, no. 5, pp. 626–638, 2017.
- H. B. Henriksson, M. Thornemo, C. Karlsson et al., “Identification of cell proliferation zones, progenitor cells and a potential stem cell niche in the intervertebral disc region: a study in four species,” Spine, vol. 34, no. 21, pp. 2278–2287, 2009.
- J. P. G. Urban and S. Roberts, “Degeneration of the intervertebral disc,” Arthritis Research & Therapy, vol. 5, no. 3, pp. 120–130, 2003.
- A. A. Hegewald, J. Ringe, M. Sittinger, and C. Thome, “Regenerative treatment strategies in spinal surgery,” Frontiers in Bioscience, vol. 13, no. 13, pp. 1507–1525, 2008.
- C. Q. Zhao, L. M. Wang, L. S. Jiang, and L. Y. Dai, “The cell biology of intervertebral disc aging and degeneration,” Ageing Research Reviews, vol. 6, no. 3, pp. 247–261, 2007.
- Y. T. Wang, X. T. Wu, and F. Wang, “Regeneration potential and mechanism of bone marrow mesenchymal stem cell transplantation for treating intervertebral disc degeneration,” Journal of Orthopaedic Science, vol. 15, no. 6, pp. 707–719, 2010.
- B. Han, H.-c. Wang, H. Li et al., “Nucleus pulposus mesenchymal stem cells in acidic conditions mimicking degenerative intervertebral discs give better performance than adipose tissue-derived mesenchymal stem cells,” Cells Tissues Organs, vol. 199, no. 5-6, pp. 342–352, 2015.
- D. Sakai and S. Grad, “Advancing the cellular and molecular therapy for intervertebral disc disease,” Advanced Drug Delivery Reviews, vol. 84, pp. 159–171, 2015.
- S. Z. Wang, Y. F. Rui, Q. Tan, and C. Wang, “Enhancing intervertebral disc repair and regeneration through biology: platelet-rich plasma as an alternative strategy,” Arthritis Research & Therapy, vol. 15, no. 5, p. 220, 2013.
- F. Wang, R. Shi, F. Cai, Y. T. Wang, and X. T. Wu, “Stem cell approaches to intervertebral disc regeneration: obstacles from the disc microenvironment,” Stem Cells and Development, vol. 24, no. 21, pp. 2479–2495, 2015.
- C. H. Evans and J. Huard, “Gene therapy approaches to regenerating the musculoskeletal system,” Nature Reviews Rheumatology, vol. 11, no. 4, pp. 234–242, 2015.
- G. Vadalà, F. Russo, L. Ambrosio, M. Loppini, and V. Denaro, “Stem cells sources for intervertebral disc regeneration,” World Journal of Stem Cells, vol. 8, no. 5, pp. 185–201, 2016.
- D. Sakai, J. Mochida, Y. Yamamoto et al., “Transplantation of mesenchymal stem cells embedded in Atelocollagen® gel to the intervertebral disc: a potential therapeutic model for disc degeneration,” Biomaterials, vol. 24, no. 20, pp. 3531–3541, 2003.
- L. Orozco, R. Soler, C. Morera, M. Alberca, A. Sánchez, and J. García-Sancho, “Intervertebral disc repair by autologous mesenchymal bone marrow cells: a pilot study,” Transplantation, vol. 92, no. 7, pp. 822–828, 2011.
- G. Vadalà, G. Sowa, M. Hubert, L. G. Gilbertson, V. Denaro, and J. D. Kang, “Mesenchymal stem cells injection in degenerated intervertebral disc: cell leakage may induce osteophyte formation,” Journal of Tissue Engineering and Regenerative Medicine, vol. 6, no. 5, pp. 348–355, 2012.
- R. Shi, F. Wang, X. Hong et al., “The presence of stem cells in potential stem cell niches of the intervertebral disc region: an in vitro study on rats,” European Spine Journal, vol. 24, no. 11, pp. 2411–2424, 2015.
- W. E. B. Johnson, S. Stephan, and S. Roberts, “The influence of serum, glucose and oxygen on intervertebral disc cell growth in vitro: implications for degenerative disc disease,” Arthritis Research & Therapy, vol. 10, no. 2, article R46, 2008.
- W. M. Erwin, D. Islam, E. Eftekarpour, R. D. Inman, M. Z. Karim, and M. G. Fehlings, “Intervertebral disc-derived stem cells: implications for regenerative medicine and neural repair,” Spine, vol. 38, no. 3, pp. 211–216, 2013.
- H. Wu, X. Zeng, J. Yu et al., “Comparison of nucleus pulposus stem/progenitor cells isolated from degenerated intervertebral discs with umbilical cord derived mesenchymal stem cells,” Experimental Cell Research, vol. 361, no. 2, pp. 324–332, 2017.
- C. H. Lee, F. Y. Lee, S. Tarafder et al., “Harnessing endogenous stem/progenitor cells for tendon regeneration,” The Journal of Clinical Investigation, vol. 125, no. 7, pp. 2690–2701, 2015.
- H. Yin, F. Price, and M. A. Rudnicki, “Satellite cells and the muscle stem cell niche,” Physiological Reviews, vol. 93, no. 1, pp. 23–67, 2013.
- R. Williams, I. M. Khan, K. Richardson et al., “Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage,” PLoS One, vol. 5, no. 10, article e13246, 2010.
- H. B. Henriksson, E. Svala, E. Skioldebrand, A. Lindahl, and H. Brisby, “Support of concept that migrating progenitor cells from stem cell niches contribute to normal regeneration of the adult mammal intervertebral disc: a descriptive study in the New Zealand white rabbit,” Spine, vol. 37, no. 9, pp. 722–732, 2012.
- M. V. Risbud, A. Guttapalli, T. T. Tsai et al., “Evidence for skeletal progenitor cells in the degenerate human intervertebral disc,” Spine, vol. 32, no. 23, pp. 2537–2544, 2007.
- J. F. Blanco, I. F. Graciani, F. M. Sanchez-Guijo et al., “Isolation and characterization of mesenchymal stromal cells from human degenerated nucleus pulposus: comparison with bone marrow mesenchymal stromal cells from the same subjects,” Spine, vol. 35, no. 26, pp. 2259–2265, 2010.
- L. Liang, X. Li, D. Li et al., “The characteristics of stem cells in human degenerative intervertebral disc,” Medicine, vol. 96, no. 25, article e7178, 2017.
- D. Sakai, Y. Nakamura, T. Nakai et al., “Exhaustion of nucleus pulposus progenitor cells with ageing and degeneration of the intervertebral disc,” Nature Communications, vol. 3, no. 1, p. 1264, 2012.
- L. T. Liu, B. Huang, C. Q. Li, Y. Zhuang, J. Wang, and Y. Zhou, “Characteristics of stem cells derived from the degenerated human intervertebral disc cartilage endplate,” PLoS One, vol. 6, no. 10, article e26285, 2011.
- C. Liu, Q. Guo, J. Li et al., “Identification of rabbit annulus fibrosus-derived stem cells,” PLoS One, vol. 9, no. 9, article e108239, 2014.
- Q. Shen, L. Zhang, B. Chai, and X. Ma, “Isolation and characterization of mesenchymal stem-like cells from human nucleus pulposus tissue,” Science China Life Sciences, vol. 58, no. 5, pp. 509–511, 2015.
- G. Feng, X. Yang, H. Shang et al., “Multipotential differentiation of human anulus fibrosus cells: an in vitro study,” The Journal of Bone and Joint Surgery-American Volume, vol. 92, no. 3, pp. 675–685, 2010.
- B. Huang, L. T. Liu, C. Q. Li et al., “Study to determine the presence of progenitor cells in the degenerated human cartilage endplates,” European Spine Journal, vol. 21, no. 4, pp. 613–622, 2012.
- M. Dominici, K. le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006.
- H. Wang, Y. Zhou, T.-W. Chu et al., “Distinguishing characteristics of stem cells derived from different anatomical regions of human degenerated intervertebral discs,” European Spine Journal, vol. 25, no. 9, pp. 2691–2704, 2016.
- S. Huang, V. Y. L. Leung, D. Long et al., “Coupling of small leucine-rich proteoglycans to hypoxic survival of a progenitor cell-like subpopulation in rhesus macaque intervertebral disc,” Biomaterials, vol. 34, no. 28, pp. 6548–6558, 2013.
- Y. Zhao, Z. Jia, S. Huang et al., “Age-related changes in nucleus pulposus mesenchymal stem cells: an in vitro study in rats,” Stem Cells International, vol. 2017, Article ID 6761572, 13 pages, 2017.
- M. Yasen, Q. Fei, W. C. Hutton et al., “Changes of number of cells expressing proliferation and progenitor cell markers with age in rabbit intervertebral discs,” Acta Biochimica et Biophysica Sinica, vol. 45, no. 5, pp. 368–376, 2013.
- O. Mizrahi, D. Sheyn, W. Tawackoli et al., “Nucleus pulposus degeneration alters properties of resident progenitor cells,” The Spine Journal, vol. 13, no. 7, pp. 803–814, 2013.
- Z. Jia, P. Yang, Y. Wu et al., “Comparison of biological characteristics of nucleus pulposus mesenchymal stem cells derived from non-degenerative and degenerative human nucleus pulposus,” Experimental and Therapeutic Medicine, vol. 13, no. 6, pp. 3574–3580, 2017.
- H. Henriksson, A. Lindahl, E. Skioldebrand et al., “Similar cellular migration patterns from niches in intervertebral disc and in knee-joint regions detected by in situ labeling: an experimental study in the New Zealand white rabbit,” Stem Cell Research & Therapy, vol. 4, no. 5, p. 104, 2013.
- C. J. Xiong, B. Huang, Y. Zhou et al., “Macrophage migration inhibitory factor inhibits the migration of cartilage end plate-derived stem cells by reacting with CD74,” PLoS One, vol. 7, no. 8, article e43984, 2012.
- P. Lama, C. L. le Maitre, I. J. Harding, P. Dolan, and M. A. Adams, “Nerves and blood vessels in degenerated intervertebral discs are confined to physically disrupted tissue,” Journal of Anatomy, vol. 233, no. 1, pp. 86–97, 2018.
- X. Chen, L. Zhu, G. Wu, Z. Liang, L. Yang, and Z. Du, “A comparison between nucleus pulposus-derived stem cell transplantation and nucleus pulposus cell transplantation for the treatment of intervertebral disc degeneration in a rabbit model,” International Journal of Surgery, vol. 28, pp. 77–82, 2016.
- L. Lin, Z. Jia, Y. Zhao et al., “Use of limiting dilution method for isolation of nucleus pulposus mesenchymal stem/progenitor cells and effects of plating density on biological characteristics and plasticity,” BioMed Research International, vol. 2017, Article ID 9765843, 16 pages, 2017.
- Y. Q. Tao, C. Z. Liang, H. Li et al., “Potential of co-culture of nucleus pulposus mesenchymal stem cells and nucleus pulposus cells in hyperosmotic microenvironment for intervertebral disc regeneration,” Cell Biology International, vol. 37, no. 8, pp. 826–834, 2013.
- Y. Tao, X. Zhou, C. Liang et al., “TGF-β3 and IGF-1 synergy ameliorates nucleus pulposus mesenchymal stem cell differentiation towards the nucleus pulposus cell type through MAPK/ERK signaling,” Growth Factors, vol. 33, no. 5-6, pp. 326–336, 2015.
- H. Li, Y. Tao, C. Liang et al., “Influence of hypoxia in the intervertebral disc on the biological behaviors of rat adipose- and nucleus pulposus-derived mesenchymal stem cells,” Cells, Tissues, Organs, vol. 198, no. 4, pp. 266–277, 2013.
- I. Sekiya, B. L. Larson, J. R. Smith, R. Pochampally, J.-G. Cui, and D. J. Prockop, “Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality,” Stem Cells, vol. 20, no. 6, pp. 530–541, 2002.
- C. Feng, Y. Zhang, M. Yang, B. Huang, and Y. Zhou, “Collagen-derived N-acetylated proline-glycine-proline in intervertebral discs modulates CXCR1/2 expression and activation in cartilage endplate stem cells to induce migration and differentiation toward a pro-inflammatory phenotype,” Stem Cells, vol. 33, no. 12, pp. 3558–3568, 2015.
- T. Ishii, D. Sakai, J. Schol, T. Nakai, K. Suyama, and M. Watanabe, “Sciatic nerve regeneration by transplantation of in vitro differentiated nucleus pulposus progenitor cells,” Regenerative Medicine, vol. 12, no. 4, pp. 365–376, 2017.
- J. Liu, H. Tao, H. Wang et al., “Biological behavior of human nucleus pulposus mesenchymal stem cells in response to changes in the acidic environment during intervertebral disc degeneration,” Stem Cells and Development, vol. 26, no. 12, pp. 901–911, 2017.
- Z. Li, S. Chen, K. Ma et al., “CsA attenuates compression-induced nucleus pulposus mesenchymal stem cells apoptosis via alleviating mitochondrial dysfunction and oxidative stress,” Life Sciences, vol. 205, pp. 26–37, 2018.
- Y. Navaro, N. Bleich-Kimelman, L. Hazanov et al., “Matrix stiffness determines the fate of nucleus pulposus–derived stem cells,” Biomaterials, vol. 49, pp. 68–76, 2015.
- L. Qi, R. Wang, Q. Shi, M. Yuan, M. Jin, and D. Li, “Umbilical cord mesenchymal stem cell conditioned medium restored the expression of collagen II and aggrecan in nucleus pulposus mesenchymal stem cells exposed to high glucose,” Journal of Bone and Mineral Metabolism, 2018.
- C. Yuan, L. Pu, Z. He, and J. Wang, “BNIP3/Bcl‑2‑mediated apoptosis induced by cyclic tensile stretch in human cartilage endplate‑derived stem cells,” Experimental and Therapeutic Medicine, vol. 15, no. 1, pp. 235–241, 2018.
- Y. Yao, Q. Deng, W. Song et al., “MIF plays a key role in regulating tissue-specific chondro-osteogenic differentiation fate of human cartilage endplate stem cells under hypoxia,” Stem Cell Reports, vol. 7, no. 2, pp. 249–262, 2016.
- H. Brisby, N. Papadimitriou, C. Brantsing, P. Bergh, A. Lindahl, and H. Barreto Henriksson, “The presence of local mesenchymal progenitor cells in human degenerated intervertebral discs and possibilities to influence these in vitro: a descriptive study in humans,” Stem Cells and Development, vol. 22, no. 5, pp. 804–814, 2013.
- H. E. Gruber, J. A. Ingram, H. J. Norton, and E. N. Hanley Jr., “Senescence in cells of the aging and degenerating intervertebral disc: immunolocalization of senescence-associated β-galactosidase in human and sand rat discs,” Spine, vol. 32, no. 3, pp. 321–327, 2007.
- S. Roberts, E. H. Evans, D. Kletsas, D. C. Jaffray, and S. M. Eisenstein, “Senescence in human intervertebral discs,” European Spine Journal, vol. 15, no. S3, pp. 312–316, 2006.
- G. Hou, H. Lu, M. Chen, H. Yao, and H. Zhao, “Oxidative stress participates in age-related changes in rat lumbar intervertebral discs,” Archives of Gerontology and Geriatrics, vol. 59, no. 3, pp. 665–669, 2014.
- L. A. Nasto, K. Ngo, A. S. Leme et al., “Investigating the role of DNA damage in tobacco smoking-induced spine degeneration,” The Spine Journal, vol. 14, no. 3, pp. 416–423, 2014.
- J. V. Chakkalakal, K. M. Jones, M. A. Basson, and A. S. Brack, “The aged niche disrupts muscle stem cell quiescence,” Nature, vol. 490, no. 7420, pp. 355–360, 2012.
- M. Komatsu, S. Waguri, T. Chiba et al., “Loss of autophagy in the central nervous system causes neurodegeneration in mice,” Nature, vol. 441, no. 7095, pp. 880–884, 2006.
- A. M. Cuervo, E. Bergamini, U. T. Brunk, W. Dröge, M. Ffrench, and A. Terman, “Autophagy and aging: the importance of maintaining "clean" cells,” Autophagy, vol. 1, no. 3, pp. 131–140, 2005.
- P. Sousa-Victor, S. Gutarra, L. García-Prat et al., “Geriatric muscle stem cells switch reversible quiescence into senescence,” Nature, vol. 506, no. 7488, pp. 316–321, 2014.
- D. Sakai and G. B. J. Andersson, “Stem cell therapy for intervertebral disc regeneration: obstacles and solutions,” Nature Reviews Rheumatology, vol. 11, no. 4, pp. 243–256, 2015.
- A. G. Nerlich, R. Schaaf, B. Wälchli, and N. Boos, “Temporo-spatial distribution of blood vessels in human lumbar intervertebral discs,” European Spine Journal, vol. 16, no. 4, pp. 547–555, 2007.
- A. J. Freemont, A. Watkins, C. le Maitre et al., “Nerve growth factor expression and innervation of the painful intervertebral disc,” The Journal of Pathology, vol. 197, no. 3, pp. 286–292, 2002.
- Y. Li, J. Zhou, X. Yang, Y. Jiang, and J. Gui, “Intermittent hydrostatic pressure maintains and enhances the chondrogenic differentiation of cartilage progenitor cells cultivated in alginate beads,” Development, Growth & Differentiation, vol. 58, no. 2, pp. 180–193, 2016.
- M.-S. Hosseini, M. Tafazzoli-Shadpour, N. Haghighipour, N. Aghdami, and A. Goodarzi, “The synergistic effects of shear stress and cyclic hydrostatic pressure modulate chondrogenic induction of human mesenchymal stem cells,” The International Journal of Artificial Organs, vol. 38, no. 10, pp. 557–564, 2015.
- Y. H. Zhao, X. Lv, Y. L. Liu et al., “Hydrostatic pressure promotes the proliferation and osteogenic/chondrogenic differentiation of mesenchymal stem cells: the roles of RhoA and Rac1,” Stem Cell Research, vol. 14, no. 3, pp. 283–296, 2015.
- P. H. Chou, S. T. Wang, M. H. Yen, C. L. Liu, M. C. Chang, and O. K. S. Lee, “Fluid-induced, shear stress-regulated extracellular matrix and matrix metalloproteinase genes expression on human annulus fibrosus cells,” Stem Cell Research & Therapy, vol. 7, no. 1, p. 34, 2016.
- C. Neidlinger-Wilke, A. Mietsch, C. Rinkler, H.-J. Wilke, A. Ignatius, and J. Urban, “Interactions of environmental conditions and mechanical loads have influence on matrix turnover by nucleus pulposus cells,” Journal of Orthopaedic Research, vol. 30, no. 1, pp. 112–121, 2012.
- Z. He, L. Pu, C. Yuan, M. Jia, and J. Wang, “Nutrition deficiency promotes apoptosis of cartilage endplate stem cells in a caspase-independent manner partially through upregulating BNIP3,” Acta Biochimica et Biophysica Sinica, vol. 49, no. 1, pp. 25–32, 2017.
- C. K. Kepler, R. K. Ponnappan, C. A. Tannoury, M. V. Risbud, and D. G. Anderson, “The molecular basis of intervertebral disc degeneration,” The Spine Journal, vol. 13, no. 3, pp. 318–330, 2013.
- C. Feng, H. Liu, M. Yang, Y. Zhang, B. Huang, and Y. Zhou, “Disc cell senescence in intervertebral disc degeneration: causes and molecular pathways,” Cell Cycle, vol. 15, no. 13, pp. 1674–1684, 2016.
- A. Rastogi, P. Thakore, A. Leung et al., “Environmental regulation of notochordal gene expression in nucleus pulposus cells,” Journal of Cellular Physiology, vol. 220, no. 3, pp. 698–705, 2009.
- F. Guilak, D. M. Cohen, B. T. Estes, J. M. Gimble, W. Liedtke, and C. S. Chen, “Control of stem cell fate by physical interactions with the extracellular matrix,” Cell Stem Cell, vol. 5, no. 1, pp. 17–26, 2009.
- J. Melrose, R. P. Bone, and Joint Research Laboratory, “Perlecan delineates stem cell niches in human foetal hip, knee and elbow cartilage rudiments and has potential roles in the regulation of stem cell differentiation,” Stem Cells Research, Development & Therapy, vol. 3, no. 1, pp. 1–7, 2016.
- U. Schlötzer-Schrehardt, T. Dietrich, K. Saito et al., “Characterization of extracellular matrix components in the limbal epithelial stem cell compartment,” Experimental Eye Research, vol. 85, no. 6, pp. 845–860, 2007.
- S. Brown, A. Matta, M. Erwin et al., “Cell clusters are indicative of stem cell activity in the degenerate intervertebral disc: can their properties be manipulated to improve intrinsic repair of the disc?” Stem Cells and Development, vol. 27, no. 3, pp. 147–165, 2018.
- S. M. Smith, C. Shu, and J. Melrose, “Comparative immunolocalisation of perlecan with collagen II and aggrecan in human foetal, newborn and adult ovine joint tissues demonstrates perlecan as an early developmental chondrogenic marker,” Histochemistry and Cell Biology, vol. 134, no. 3, pp. 251–263, 2010.
- C. Shu, C. Hughes, S. M. Smith et al., “The ovine newborn and human foetal intervertebral disc contain perlecan and aggrecan variably substituted with native 7D4 CS sulphation motif: spatiotemporal immunolocalisation and co-distribution with Notch-1 in the human foetal disc,” Glycoconjugate Journal, vol. 30, no. 7, pp. 717–725, 2013.
- Y. K. Wang and C. S. Chen, “Cell adhesion and mechanical stimulation in the regulation of mesenchymal stem cell differentiation,” Journal of Cellular and Molecular Medicine, vol. 17, no. 7, pp. 823–832, 2013.
- S. D. Subramony, B. R. Dargis, M. Castillo et al., “The guidance of stem cell differentiation by substrate alignment and mechanical stimulation,” Biomaterials, vol. 34, no. 8, pp. 1942–1953, 2013.
- X. F. Li, P. Leng, Z. Zhang, and H. N. Zhang, “The Piezo1 protein ion channel functions in human nucleus pulposus cell apoptosis by regulating mitochondrial dysfunction and the endoplasmic reticulum stress signal pathway,” Experimental Cell Research, vol. 358, no. 2, pp. 377–389, 2017.
- J. S. Choi and B. A. C. Harley, “The combined influence of substrate elasticity and ligand density on the viability and biophysical properties of hematopoietic stem and progenitor cells,” Biomaterials, vol. 33, no. 18, pp. 4460–4468, 2012.
- D. Seliktar, “Designing cell-compatible hydrogels for biomedical applications,” Science, vol. 336, no. 6085, pp. 1124–1128, 2012.
- A. J. Engler, H. L. Sweeney, D. E. Discher, and J. E. Schwarzbauer, “Extracellular matrix elasticity directs stem cell differentiation,” Journal of Biomechanics, vol. 7, no. 4, p. 335, 2007.
- A. H. Hsieh and J. D. Twomey, “Cellular mechanobiology of the intervertebral disc: new directions and approaches,” Journal of Biomechanics, vol. 43, no. 1, pp. 137–145, 2010.
- Y. Sun, T. L. Wang, W. S. Toh, and M. Pei, “The role of laminins in cartilaginous tissues: from development to regeneration,” European Cells and Materials, vol. 34, pp. 40–54, 2017.
- C. B. Foldager, W. S. Toh, B. B. Christensen, M. Lind, A. H. Gomoll, and M. Spector, “Collagen type IV and laminin expressions during cartilage repair and in late clinically failed repair tissues from human subjects,” Cartilage, vol. 7, no. 1, pp. 52–61, 2016.
- C. B. Foldager, W. S. Toh, A. H. Gomoll, B. R. Olsen, and M. Spector, “Distribution of basement membrane molecules, laminin and collagen type IV, in normal and degenerated cartilage tissues,” Cartilage, vol. 5, no. 2, pp. 123–132, 2014.
- N. L. Nerurkar, B. M. Baker, S. Sen, E. E. Wible, D. M. Elliott, and R. L. Mauck, “Nanofibrous biologic laminates replicate the form and function of the annulus fibrosus,” Nature Materials, vol. 8, no. 12, pp. 986–992, 2009.
- J. Hashimoto, Y. Kariya, and K. Miyazaki, “Regulation of proliferation and chondrogenic differentiation of human mesenchymal stem cells by laminin-5 (laminin-332),” Stem Cells, vol. 24, no. 11, pp. 2346–2354, 2006.
- W. S. Toh, C. B. Foldager, B. R. Olsen, and M. Spector, “Basement membrane molecule expression attendant to chondrogenesis by nucleus pulposus cells and mesenchymal stem cells,” Journal of Orthopaedic Research, vol. 31, no. 7, pp. 1136–1143, 2013.
- S. Rodin, L. Antonsson, C. Niaudet et al., “Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin matrix in defined and xeno-free environment,” Nature Communications, vol. 5, no. 1, 2014.
- A. Laperle, C. Hsiao, M. Lampe et al., “α-5 laminin synthesized by human pluripotent stem cells promotes self-renewal,” Stem Cell Reports, vol. 5, no. 2, pp. 195–206, 2015.
- Y. Tao, X. Zhou, D. Liu et al., “Proportion of collagen type II in the extracellular matrix promotes the differentiation of human adipose-derived mesenchymal stem cells into nucleus pulposus cells,” BioFactors, vol. 42, no. 2, pp. 212–223, 2016.
- G. Fontana, D. Thomas, E. Collin, and A. Pandit, “Microgel microenvironment primes adipose-derived stem cells towards an NP cells-like phenotype,” Advanced Healthcare Materials, vol. 3, no. 12, pp. 2012–2022, 2014.
- Y. Bi, D. Ehirchiou, T. M. Kilts et al., “Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche,” Nature Medicine, vol. 13, no. 10, pp. 1219–1227, 2007.
- H. Kizawa, I. Kou, A. Iida et al., “An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis,” Nature Genetics, vol. 37, no. 2, pp. 138–144, 2005.
- T. Furukawa, K. Ito, S. Nuka et al., “Absence of biglycan accelerates the degenerative process in mouse intervertebral disc,” Spine, vol. 34, no. 25, pp. E911–E917, 2009.
- M. Yuan, C. W. Yeung, Y. Y. Li et al., “Effects of nucleus pulposus cell-derived acellular matrix on the differentiation of mesenchymal stem cells,” Biomaterials, vol. 34, no. 16, pp. 3948–3961, 2013.
- R. Maidhof, A. Rafiuddin, F. Chowdhury, T. Jacobsen, and N. O. Chahine, “Timing of mesenchymal stem cell delivery impacts the fate and therapeutic potential in intervertebral disc repair,” Journal of Orthopaedic Research, vol. 35, no. 1, pp. 32–40, 2017.
- C.-A. Grégoire, B. L. Goldenstein, E. M. Floriddia, F. Barnabé-Heider, and K. J. L. Fernandes, “Endogenous neural stem cell responses to stroke and spinal cord injury,” Glia, vol. 63, no. 8, pp. 1469–1482, 2015.
- K. J. Dixon, M. H. Theus, C. M. Nelersa et al., “Endogenous neural stem/progenitor cells stabilize the cortical microenvironment after traumatic brain injury,” Journal of Neurotrauma, vol. 32, no. 11, pp. 753–764, 2015.
- H. Lin, H. Ouyang, J. Zhu et al., “Lens regeneration using endogenous stem cells with gain of visual function,” Nature, vol. 531, no. 7594, pp. 323–328, 2016.
- Z. Huang, L. Zhang, X. Feng, T. Chen, and S. Bi, “A new in vivo method to retard progression of intervertebral disc degeneration through stimulation of endogenous stem cells with simvastatin,” Medical Hypotheses, vol. 101, pp. 65-66, 2017.
Copyright © 2018 Binwu Hu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.